Immunohistochemical analysis of Hodgkin’s lymphoma tumor samples from patients treated with SGN-35 revealed significant changes in the number of intra-tumoral CD8+ effector T cells (Theurich et al., 2013). The gene discussed is CD8A; the disease is neoplasm.